CX-1440
邦赛替尼
Report date: 2026/03/11 20:02:12
NME
Base Information
Drug NameCX-1440
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[11]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesHangzhou Sanyintai Pharmaceutical Technology Co LtdHangzhou Aojin Biomedical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesHangzhou Bangshun Pharmaceutical Co LtdHangzhou Aojin Biomedical Technology Co LtdHangzhou Sanyintai Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active Indications +[9]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A